BioPlan Associates - Biopharmaceutical Manufacturing Capacity & Production

Lynn Johnson Langer, Ph.D., Board Member: elected president of Women In Biotech. She also serves on its Board of Directors. Women In Biotech is an organization with chapters across the United States. WIB is dedicated to serving all women in the bioscience industry through professional development programs, workshops, seminars and networking opportunities.

Ron Rader, Sr. Dir. Technical Research: named Editor-in-Chief of Biopharmaceuticals a new peer-reviewed journal from Landes Bioscience. Biopharmaceuticals is the first and only peer-reviewed journal about biopharmaceuticals. Biopharmaceuticals seeks submission of articles concerning biopharmaceuticals and the industry. Please contact the Editor-in-Chief if interested in submitting an article.

Dr Faiz Kermani, Advisory Board: Has helped establish the "Global Health Education Foundation" (GHEF), a not-for-profit healthcare charity to improve educational resources and training for healthcare professionals in developing countries.
At least 1.3 billion people worldwide lack access to the most basic healthcare. The new non-profit foundation, Global Health Education Foundation, aims to tackle such issues. As President of GHEF, Dr Kermani is supporting the R&D focus of the charity to reduce health disparities among developing countries. In particular, the lack of appropriate educational resources and training opportunities for healthcare professionals. http://www.globalhef.org

Eric Langer, Managing Partner: On Advisory Board of “BioProcess Asia Pacific Conference” July 2010 Singapore.
The Biopharmaceutical market in Asia pacific is growing at a rate among the highest in the globe. This is creating a strong need for production of biopharmaceuticals at higher qualities and volumes. Bioprocess AsiaPacific brings together global leaders within biopharmaceutical industry to explore dynamic strategies, benchmark technologies and analyze sustaining the growth of the industry. http://fleminggulf.com/conference/life-science/BioProcessAsiaPacific.

BioPlan Associates’ Board Member Lynn Johnson Langer, Ph.D. was recently sworn in by Maryland Governor Martin O’Malley to the Maryland Technology Development Corporation (TEDCO) Board of Directors.
In addition to her roles with TEDCO and BioPlan Associates, Dr. Langer is the Faculty/ProgramDirector of Bioenterprise and Regulatory Affairs for the Johns Hopkins University.



Directory of Top 60 Biopharmaceutical Manufacturers in India	8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production	Advances in Biopharmaceutical Technology in China
>> more Reports

Publications, Reports and Books

The 2011 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production. This year's 8th Annual Report and Survey of Biopharmaceutical Manufacturing shows the industry has returned to robust growth. Based on analysis of 352 global biomanufacturers' 2011 budgets, expect substantial investment in new technologies that:

Reduce costs and improve productivity
Focus on novel downstream technologies
Improve single-use device adoption rates

This year, among the 100s of significant findings: Budgets are growing in all areas measured, but the great majority are continuing to actively implement cost-cutting initiatives; a broad range of new products are being demanded from industry vendors to solve productivity problems, especially in single use and chromatography areas.

Published by BioPlan Associates, Inc. April 2011
ISBN 978-1-934106-21-1

Download Brochure 216k

Download Table of Contents 397k

Hardcover	Digital Global License

Coverage
Table of Contents Overview
By the Numbers

This report's 492 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more:

Budget impact of current economic environment
Downstream purification problems and issues
Novel technologies
Disposables analysis
Current industry bottlenecks
Capacity utilization and current production levels
Current & Projected bottlenecks, 5-year trends
Production trends and implications
Outsourcing trends
Expression system advances
Range of titres
Disposables: Spending, downstream, L&E's, trends & reasons; vendor satisfaction
Batch failure rates & trends
Selecting a CMO: Problems & solutions
Quality management & PAT implementation
Hiring and employment growth
Supplier growth rates
Training and management

Compare 352 biotherapeutic developers vs CMOs; US vs European & Global Biomanufacturing

Overview
Methodology
CHAPTER 1: Introduction and Discusssion
CHAPTER 2: Demographics
CHAPTER 3: Emerging Issues in Biopharmaceutical Manufacturing
CHAPTER 4: Capacity Utilization
CHAPTER 5: Current Capacity Constraints
CHAPTER 6: Future Capacity Expansions
CHAPTER 7: Outsourcing Trends in Biopharmaceutical Manufacturing
CHAPTER 8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing
CHAPTER 9: Downstream Purification
CHAPTER 10: Quality Issues, Batch Failures, and PAT in Biopharmaceutical Manufacturing
CHAPTER 11: Hiring, Employment Growth, and Training in Biopharmaceutical Manufacturing
CHAPTER 12: Suppliers to Biopharmaceutical Manufacturing and Life Sciences

Download the complete Table of Contents 397k

492 Pages
352 Biomanufacturers and CMOs surveyed
186 Direct industry suppliers
31 Countries represented
492 pages (20% more info than last year!)
12 Chapters
195 Graphs and 20 tables
35 Subject Matter Experts providing analysis
16 Independent Sponsoring Organizations